← Back to Investors

Hatteras Venture Partners

Hatteras Venture Partners is an early-stage life sciences venture capital firm based in Research Triangle Park, North Carolina. They invest in therapeutics and medical devices companies, leveraging the strong research ecosystem of the Research Triangle region.

Location
Durham, North Carolina, USA
Founded
2001
AUM
$500M+
Investment Range
$500K - $15M
Focus
biotech-focused
Fund Stages
seed, series-a, series-b

Investment Thesis

Hatteras focuses on seed and early-stage investments in life sciences companies, particularly those emerging from the Research Triangle's leading universities and research institutions. They invest in therapeutics and medical devices with a focus on innovative science and strong management teams.

Team

Partners / Managing Directors (Health & Bio Focus)

  • John Crumpler - Co-Founder & Managing Director
  • John Darsee, MD - Managing Director
  • Bob Ingram - Partner

Other Key Team Members

  • Chris Caplice - Principal

Focus Areas

  • Therapeutics (oncology, rare diseases)
  • Medical devices
  • Diagnostics
  • Drug discovery
  • Biopharmaceuticals
  • North Carolina life sciences ecosystem

Notable Exits

  • G1 Therapeutics - IPO (2017, oncology)
  • Bioventus - IPO (2021)
  • Clearside Biomedical - IPO (2016)

Sources